For the Inventor, By the Inventor

Enter assignee name

Rhone-Poulenc Sante

USPTO Granted Patents = 192

Forward Citations = 1,632

Loading Chart...

Loading Chart...

186 inventors (with patents filed for the assignee):

Daniel Farge (29 out of 89 patents)

Claude Cotrel (18 out of 45 patents)

Claude James (18 out of 27 patents)

4. Christian L Renault (13 out of 22 patents)

5. Gerard Roussel (12 out of 18 patents)

6. Didier Morel (12 out of 19 patents)

7. Jean-Marc Paris (11 out of 21 patents)

8. Michel Mulhauser (11 out of 15 patents)

9. Jean-Francois Peyronel (10 out of 30 patents)

10. Jean-Luc Malleron (9 out of 32 patents)

11. Claude Guyon (9 out of 24 patents)

12. Daniel Lave (9 out of 9 patents)

13. Marie-Christine Dubroeucq (9 out of 27 patents)

14. Gerard Mignani (8 out of 41 patents)

15. Claude Gueremy (8 out of 14 patents)

Core Competencies:

Enantioselective Amidases

Thioformamide Derivatives

Terpene Derivatives

Sustained Release Formulations

Serotonin Antagonists

Isoindolone Derivatives

Pyrrole Derivatives

Analgesic Phenothiazine Derivatives

ACAT Inhibitory Benzanilides

Chitosan Derivatives

Palladium-Based Catalyst

Fermentation Process

192 patents: Sort by Forward Citations

1. 5766918 - Enantioselective amidases and uses thereof (1998-06-16),

2. 5426117 - N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide to (1995-06-20),

3. 5304642 - Pristinaymcinia or virginiamycin derivatives and their preparation (1994-04-19),

4. 5298248 - Method for continuous liberation of active constituents into water (1994-03-29),

5. 5276045 - Thioformamide derivative, process for its preparation, pharmaceutical (1994-01-04),

6. 5274178 - Terpene derivatives, their preparation and their use (1993-12-28),

7. 5260208 - Enantioselective amidases, DNA sequences encoding them, method of (1993-11-09),

8. 5246950 - Thioformamide derivatives (1993-09-21),

9. 5244881 - Compositions based on imipyramine (1993-09-14),

10. 5236940 - Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their (1993-08-17),

11. 5223529 - N-phenylamides and medicinal products containing them (1993-06-29),

12. 5206025 - Porous pharmaceutical form and its preparation (1993-04-27),

13. 5202460 - Terpene derivatives, their preparation and their use (1993-04-13),

14. 5188841 - Sustained release pharmaceutical formulations (1993-02-23),

15. 5188838 - Process for the preparation of medications in the form of pearls (1993-02-23),

Rhone-Poulenc Sante is a leading global pharmaceutical company that specializes in the research, development, and manufacturing of innovative healthcare solutions. With a focus on improving patient outcomes and providing advanced medical treatments, Rhone-Poulenc Sante is committed to delivering high-quality products and services. Our dedication to scientific excellence and strong partnerships with healthcare professionals make us a trusted name in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

192 Patents

#6 in

#139 in France

#4,262 in the World

Rhone-Poulenc Sante

Forward Citations = 1,632

186 inventors:

Daniel Farge (29 out of 89 patents)

Claude Cotrel (18 out of 45 patents)

Claude James (18 out of 27 patents)

4. Christian L Renault (13 out of 22 patents)

5. Gerard Roussel (12 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…